| Ytd | -26.59% | |
| 1y | 208.22% |
| Open | 4.48 | Prev Close | 4.53 | Low | 4.44 | High | 4.58 | Mkt Cap | 95.58M |
| Vol | 0.00 | Avg Vol | 210.16K | EPS | -2.36 | P/E | -1.91 | Forward P/E | -2.52 |
| Beta | 0.22 | Short Ratio | 2.72 | Inst. Own | 42.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.02 | 200-d Avg | 4.45 | 1yr Est | 19.91 |
CAMP News
CAMP4 Therapeutics Corporation (CAMP) came out with a quarterly loss of $0.22 per share versus the Z
Secured regulatory clearance in two jurisdictions to initiate first-in-human Phase 1/2 clinical tria
CAMP4 Therapeutics received regulatory clearance in Australia and Argentina to begin a Phase 1/2 tri
New woodsy-themed family area will feature nine attractions, including the Midwest's longest, talles
Proceeds of $50.1 million will be used to support the Company's advancement of CMP-002 for the treat
Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday'
Achieving Key Regulatory Milestone and Positioning the Company for its Next Phase of Growth Vancouve
Planned first-in-human clinical trial to assess a disease modifying intervention for patients with S
Planned first-in-human clinical trial to assess a disease modifying intervention for patients with S
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
CAMBRIDGE, Mass. , July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the
AYTU, CAMP and CRC have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2026.
CAMBRIDGE, Mass. , June 19, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the
Live demo listening session to approve artists onto the platform in real time New “golden ticket” su
Canadian GoldCamps says Mercator resampling returned gold in 82% of samples, confirming mineralizati
Company to advance NI 43-101 Technical Report; 2026 exploration campaign to follow up on promising h
CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the C
CMP-002 administration resulted in a statistically significant improvement in seizure phenotypes and
CAMP4 Therapeutics Corporation (CAMP) came out with a quarterly loss of $0.32 per share versus the Z
Submitted first clinical trial regulatory filing for CMP-002 in Australia, with additional global re
Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it believ
Vancouver, British Columbia – TheNewswire - April 21, 2026 – Canadian GoldCamps Corp. (CSE: CAMP) (O
CAMBRIDGE, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the
Wall Street analysts changed outlook on top names. See complete view of rating changes, including up
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group an
On Friday, 199 companies reached new 52-week lows.
On Thursday, 498 companies reached new 52-week lows.
On Wednesday, 345 companies set new 52-week lows.
During Wednesday's trading, 123 companies set new 52-week lows.
On Tuesday, 91 stocks hit new 52-week lows.
During Wednesday's trading, 517 companies set new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
Monday saw 825 companies set new 52-week lows.
On Thursday, 588 stocks hit new 52-week lows.
During Wednesday's morning trading, 400 companies set new 52-week lows.
During Tuesday's morning trading, 87 companies set new 52-week lows.
Before 10 a.m. ET on Tuesday, 165 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Friday
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018